OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MANSARD55

AXA Mansard Insurance PLC

Life & Health InsuranceVerified

AXA Mansard maintains a relatively strong liquidity position, with a free cash flow of NGN 13.36 billion and operating cash flow of NGN 29.24 billion in the latest reporting period. The company's debt-to-equity ratio is 0.2, indicating a conservative capital structure with limited leverage. However, the risk assessment notes that net cash is negative after subtracting total debt, suggesting potential liquidity constraints if short-term obligations increase. The company's profitability is reflected in a return on equity (ROE) of 19.11% and a return on assets (ROA) of 5.23%. These figures are strong relative to the industry's typical performance, indicating efficient use of equity and assets to generate returns. The operating income of NGN 13.78 billion and net income of NGN 11.25 billion further support the company's profitability. AXA Mansard's revenue is concentrated in the Nigerian market, with no disclosed international operations. The company's business is primarily driven by its life and health insurance segments, with no material diversification into other financial services. This concentration may expose the company to local economic and regulatory risks. The company's growth trajectory is not explicitly outlined in the latest financial data, but the positive operating and net income figures suggest stable performance. No significant revenue growth or decline is reported in the available data. The capital expenditure of NGN -607.83 million indicates a reduction in investment in physical assets, which may reflect a focus on cost control or a shift toward digital transformation. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company has not issued additional shares in the latest reporting period, and the diluted and basic shares outstanding remain equal at 9 billion. The risk of dilution is low, but the negative net cash position after debt suggests a need for careful liquidity management. No recent events such as filings or transcripts are disclosed in the available data. The company's financial performance appears to be stable, with no immediate signs of distress or significant operational changes.

30-day price · MANSARD-1.50 (-9.3%)
Low$13.00High$16.00Close$14.55As of15 May, 00:00 UTC
Profile
CompanyAXA Mansard Insurance PLC
TickerMANSARD.LG
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. AXA Mansard Insurance PLC provides life and health insurance services in Nigeria, generating revenue primarily through premium income and investment returns on its insurance reserves.

Classification. AXA Mansard is classified under the Life & Health Insurance industry within the Financials sector, with a high confidence level of 0.92 based on verified market data.

AXA Mansard maintains a relatively strong liquidity position, with a free cash flow of NGN 13.36 billion and operating cash flow of NGN 29.24 billion in the latest reporting period. The company's debt-to-equity ratio is 0.2, indicating a conservative capital structure with limited leverage. However, the risk assessment notes that net cash is negative after subtracting total debt, suggesting potential liquidity constraints if short-term obligations increase. The company's profitability is reflected in a return on equity (ROE) of 19.11% and a return on assets (ROA) of 5.23%. These figures are strong relative to the industry's typical performance, indicating efficient use of equity and assets to generate returns. The operating income of NGN 13.78 billion and net income of NGN 11.25 billion further support the company's profitability. AXA Mansard's revenue is concentrated in the Nigerian market, with no disclosed international operations. The company's business is primarily driven by its life and health insurance segments, with no material diversification into other financial services. This concentration may expose the company to local economic and regulatory risks. The company's growth trajectory is not explicitly outlined in the latest financial data, but the positive operating and net income figures suggest stable performance. No significant revenue growth or decline is reported in the available data. The capital expenditure of NGN -607.83 million indicates a reduction in investment in physical assets, which may reflect a focus on cost control or a shift toward digital transformation. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company has not issued additional shares in the latest reporting period, and the diluted and basic shares outstanding remain equal at 9 billion. The risk of dilution is low, but the negative net cash position after debt suggests a need for careful liquidity management. No recent events such as filings or transcripts are disclosed in the available data. The company's financial performance appears to be stable, with no immediate signs of distress or significant operational changes.
Key takeaways
  • AXA Mansard has a strong ROE of 19.11% and ROA of 5.23%, indicating efficient capital use.
  • The company maintains a conservative debt-to-equity ratio of 0.2, suggesting a low leverage profile.
  • Free cash flow of NGN 13.36 billion supports liquidity, but net cash is negative after subtracting total debt.
  • Revenue is concentrated in the Nigerian market, with no international diversification.
  • The company has not issued additional shares in the latest period, and dilution risk is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyNGN
Revenue
Gross profit
Operating income$13.78B
Net income$11.25B
R&D
SG&A
D&A
SBC
Operating cash flow$29.24B
CapEx-$607.8M
Free cash flow$13.36B
Total assets$215.01B
Total liabilities$156.13B
Total equity$58.88B
Cash & equivalents
Long-term debt$11.53B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$6.07B$3.16B$1.53B
FY-3$3.76B$2.75B-$501.1M
FY-2$919.8M$11.48B$7.82B
FY-1$5.36B$24.87B$22.45B
FY0$8.26B$2.63B-$3.80B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$103.16B$30.46B
FY-3$105.29B$29.00B
FY-2$141.13B$36.75B
FY-1$193.61B$47.11B
FY0$227.94B$52.30B
PeriodOCFCapExFCFSBC
FY-4$7.74B-$1.16B$1.53B
FY-3-$2.17B-$1.27B-$501.1M
FY-2$10.90B-$2.09B$7.82B
FY-1$37.44B-$1.85B$22.45B
FY0$13.25B-$2.35B-$3.80B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$13.78B$11.25B$13.36B
FQ-6$2.76B$5.53B$1.74B
FQ-5-$2.68B-$4.55B-$4.51B
FQ-4$6.39B$6.17B$5.82B
FQ-3$1.86B$646.4M$417.9M
FQ-2-$1.12B-$1.18B-$4.96B
FQ-1-$1.12B-$3.00B-$5.08B
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$215.01B$58.88B
FQ-6$210.72B$61.12B-$1.0k
FQ-5$193.61B$47.11B
FQ-4$244.73B$55.00B
FQ-3$234.02B$56.99B
FQ-2$220.58B$56.33B
FQ-1$227.94B$52.30B
FQ0$113.43B
PeriodOCFCapExFCFSBC
FQ-7$29.24B-$607.8M$13.36B
FQ-6-$3.91B-$1.20B$1.74B
FQ-5$37.44B-$1.85B-$4.51B
FQ-4-$13.76B-$814.0M$5.82B
FQ-3-$5.50B-$1.44B$417.9M
FQ-2$1.22B-$1.89B-$4.96B
FQ-1$13.25B-$2.35B-$5.08B
FQ0-$11.69B-$488.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$58.88B
Net cash-$11.53B
Current ratio
Debt/Equity0.2
ROA5.2%
ROE19.1%
Cash conversion2.6%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricMANSARDActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity20.0%27.5% medp25 4.7% · p75 66.5%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:07 UTC#5ea7753f
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 12:12 UTCJob: 72e7ba5b